| scholarly article | Q13442814 |
| P50 | author | Elyse R Thakur | Q86661394 |
| P2093 | author name string | Gary J Iacobucci | |
| Jeffrey M Lackner | |||
| Gregory D Gudleski | |||
| Brennan Mr Spiegel | |||
| Travis J Stewart | |||
| P2860 | cites work | Negative affectivity: the disposition to experience aversive emotional states | Q28267580 |
| A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity | Q29547290 | ||
| Self-rated health and mortality: a review of twenty-seven community studies | Q29615574 | ||
| Functional bowel disorders | Q29620328 | ||
| Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis | Q33910329 | ||
| Common method biases in behavioral research: a critical review of the literature and recommended remedies | Q34265850 | ||
| Supportive interactions, negative interactions, and depressed mood | Q34278017 | ||
| Burden of gastrointestinal disease in the United States: 2012 update | Q34293512 | ||
| The role of psychological and biological factors in postinfective gut dysfunction | Q35354188 | ||
| Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors | Q35435130 | ||
| Defining the patient-physician relationship for the 21st century | Q36019586 | ||
| The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome | Q36309936 | ||
| Impact of patient-reported outcome measures on routine practice: a structured review | Q36598942 | ||
| Role of infection in irritable bowel syndrome | Q36713061 | ||
| Patient-reported outcomes in gastroenterology: clinical and research applications | Q36817391 | ||
| Negative affect relates to cross-sectional but not longitudinal symptom reporting: data from elderly adults | Q36821145 | ||
| Negative aspects of close relationships are more strongly associated than supportive personal relationships with illness burden of irritable bowel syndrome | Q36904034 | ||
| Psychosocial predictors of self-reported fatigue in patients with moderate to severe irritable bowel syndrome | Q37090536 | ||
| Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome | Q37189148 | ||
| International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit | Q37237195 | ||
| Behavior as the central outcome in health care | Q38017241 | ||
| 2012 David Sun lecture: helping your patient by helping yourself--how to improve the patient-physician relationship by optimizing communication skills | Q38091262 | ||
| Elderly people's ratings of the importance of health-related factors to their self-assessments of health | Q40600030 | ||
| Positive affect and function as influences on self-assessments of health: expanding our view beyond illness and disability | Q40766850 | ||
| Organizing care for patients with chronic illness | Q41241070 | ||
| Neuroticism influences brain activity during the experience of visceral pain | Q43869938 | ||
| Multidimensionality of health status in an elderly population. Construct validity of a measurement battery | Q44285259 | ||
| Clinical determinants of health-related quality of life in patients with irritable bowel syndrome | Q47343026 | ||
| The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval | Q47612635 | ||
| Psychosocial Factors Are More Important Than Disease Activity in Determining Gastrointestinal Symptoms and Health Status in Adults at a Celiac Disease Referral Center | Q50545433 | ||
| Testing the sequential model of pain processing in irritable bowel syndrome: a structural equation modeling analysis | Q50977214 | ||
| The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale | Q50997548 | ||
| Neuroticism, somatic complaints, and disease: is the bark worse than the bite? | Q51198594 | ||
| A new approach to the assessment of the treatment effects of somatoform disorders. | Q51945949 | ||
| Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. | Q53348988 | ||
| A Theory of Social Comparison Processes | Q55870772 | ||
| Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations | Q59351353 | ||
| The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress | Q60707901 | ||
| What do global self-rated health items measure? | Q72198931 | ||
| Improving outcomes in chronic illness | Q77059424 | ||
| Negative interaction and heart disease in late life: exploring variations by socioeconomic status | Q81152304 | ||
| Cognitive science speaks to the "common-sense" of chronic illness management | Q82772020 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 224-233 | |
| P577 | publication date | 2014-01-14 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | The impact of physical complaints, social environment, and psychological functioning on IBS patients' health perceptions: looking beyond GI symptom severity | |
| P478 | volume | 109 |
| Q42375222 | Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. |
| Q36207210 | Biopsychosocial Approach of Gastrointestinal Disorders |
| Q38855986 | British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). |
| Q37632259 | Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice |
| Q64943937 | Developing a diagnostic understanding of GERD phenotypes through the analysis of levels of mucosal injury, immune activation, and psychological comorbidity. |
| Q35988724 | Exploring the Strange New World of Non-Celiac Gluten Sensitivity |
| Q48049237 | Fatigue: a distressing symptom for patients with irritable bowel syndrome |
| Q57789296 | Functional dyspepsia |
| Q34546729 | Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis |
| Q33651950 | Genes, emotions and gut microbiota: The next frontier for the gastroenterologist |
| Q37564164 | Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet? |
| Q33463901 | Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. |
| Q35565145 | Irritable bowel syndrome: an integrated explanatory model for clinical practice |
| Q35843069 | Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation |
| Q48104300 | Perceived Stress, Its Physiological Correlates, and Quality of Life in Patients With Irritable Bowel Syndrome. |
| Q47554094 | Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals |
| Q47547774 | Prevalence of musculoskeletal disorders and its relation to depression among workers in kindergarten. |
| Q49584033 | Randomized Double-Blind Placebo-Controlled Crossover Trial for the Diagnosis of Non-Celiac Gluten Sensitivity in Children |
| Q37641054 | Serotonin Transporter Gene (SLC6A4) Polymorphism and Mucosal Serotonin Levels in Southeastern Iranian Patients with Irritable Bowel Syndrome |
| Q42498868 | Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility. |
| Q93186295 | The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome |
| Q92111517 | The Serum Levels of CCL2 and CCL16 Expression in Patients with Irritable Bowel Syndrome |
| Q33466935 | The crossroads of gastroenterology and psychiatry - what benefits can psychiatry provide for the treatment of patients suffering from gastrointestinal symptoms |
| Q48238295 | The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice |
| Q26739291 | The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments |
Search more.